KTC
IMGN

Kistler-Tiffany Companies’s Immunogen Inc IMGN Stock Holding History

Kistler-Tiffany Companies’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$1K – 769
2021
Q3 		$1K Hold
100
– – ﹤0.01% 728
2021
Q2 		$1K Buy
+100
New +$698 ﹤0.01% 721

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Kistler-Tiffany Companies's IMGN Position: Q4 2021 in Review

Kistler-Tiffany Companies sold out of Immunogen Inc (IMGN) in Q4 2021, closing a stake of 100 shares — an estimated $1K sold.

Kistler-Tiffany Companies first reported a position in IMGN in Q2 2021 and held it in 2 quarters. The position peaked at $1K in Q3 2021. 236 funds tracked by Wall St. Rank hold IMGN as of Q4 2021.

  • Kistler-Tiffany Companies reported no remaining Immunogen Inc position as of Q4 2021 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 100 Immunogen Inc shares in Q4 2021, an estimated $1K.
  • Kistler-Tiffany Companies first reported a position in Immunogen Inc in Q2 2021 and held it in 2 quarters.
  • Kistler-Tiffany Companies's Immunogen Inc position peaked at $1K in Q3 2021.
  • 236 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2021.

Based on Kistler-Tiffany Companies's 13F filing for Q4 2021, filed 25 Jan 2022.